Category: News

Customer-focused healthcare company Wellnex Life (ASX: WNX) has announced that it has added Australian pharmaceutical giant Chemist Warehouse to its SAS-B medicinal cannabis joint venture (JV) with OneLife Botanicals, and will be launching five new products throughout Chemist Warehouse’s extensive network. 

Markets have rapidly readjusted their expectations of the terminal rates for many major world economies in the fallout from the Silicon Valley Bank Collapse (SVB). Forecasts of another 50 basis point rate hike by the Fed later this month have dropped to 40% (down from 80%), and the RBA’s peak is now priced in at 3.9%, down from 4.1%. Traders now place a 72% chance on the Australian central bank holding rates at 3.6% during its April meeting, up from 52% last week.

Every second week we invite a leading fund manager to present at The Insider: Meet the Fund Manager. In September 2022, Hancock & Gore’s Joseph Constable selected financial services provider Centrepoint Alliance as one of his favourite stocks, highlighting how…

The world has endured through and excelled at many technological innovations over the past 40 years that have drastically changed people’s way of life, and the speed of adoption is constantly getting faster. It took 122 years since the first telephone call in 1876 for there to be one phone for every person in the US, but it took only 14 years since the release of Apple’s revolutionary iPhone in 2007 for 85% of American adults to use a smartphone.

Thinking of ‘cycling through the streets of Paris’ paints a near perfect picture of charming laneways with an abundance of cafés, the sounds of an accordion bouncing off stone buildings rich with architecture and – if one business owner has anything to do with it – funerals.

In the lead up to this week’s The Insider: Meet the Fund Manager, Jai Mirchandani from ELM Responsible Investments sat down with Reach Markets to provide a bit of information about his investment strategy, methods of ESG analysis, industries of interest and view on the market.

Clinical stage oncology company, Prescient Therapeutics (ASX: PTX), has received an expanded Orphan Drug Designation (ODD) from the Food and Drug Administration (FDA) for its targeted cell therapy PTX-100 that now extends to all T-cell lymphomas (TCLs). This is an encouraging signal from the US regulatory agency, who had already awarded the asset ODD for its potential to treat Peripheral T-cell Lymphoma – and aggressive cancer with an average 5-year survival rate of 32%.

Happy International Women’s Day! I’d like to acknowledge the immense talent, skills, determination and strength that women contribute to Reach. 

Every second week we invite a leading fund manager to present at The Insider: Meet the Fund Manager. In June 2022, Equitable Investors’ Martin Pretty, CFA, selected Locality Planning Energy Holdings (ASX: LPE) as one of his favourite stocks for…

The sudden increase in electric vehicle (EV) demand that stormed the economy over the last couple of years certainly caught the market off guard. A supply chain that was unprepared even before covid, as well as an incredibly tight lithium supply that became extraordinarily exposed, did little to hamper growth in EV sales.

Everything Italy and (soon) the rest of the world knows and loves about coffee is about to change. Starbucks has stirred up caffeine culture by introducing a range of coffee-based beverages infused with a popular yet unlikely ingredient – olive oil.

Saudi Arabia is synonymous with oil, holding 16% of the world’s oil reserves which contribute 70% to the value of the country’s exports and 46% to its GDP.